Abstract:Background: Very early-onset inflammatory bowel disease (VEO-IBD) occurs in young children and causes severe clinical manifestations which have poor responses to traditional IBD treatments. At present, there are no simple and reliable laboratory indicators for early screening VEO-IBD patients especially those who were caused by monogenic diseases. Methods: A retrospective analysis was performed in 73 patients with VEO-IBD admitted to our hospital in the past 5 years. Based on the next-generation sequencing results they were divided into monogenic IBD group (M-IBD) and non-monogenic IBD group (NM-IBD). Forty age-matched patients with allergic proctocolitis were the control group (food allergy, FA). Evaluating the clinical manifestations and the inflammatory factors in peripheral blood. The logistic regression analysis and receiver operating characteristic (ROC) curve analysis were used to find the screening factors and cut-off values of VEO-IBD as well as monogenic VEO-IBD, respectively. Findings: Among the 73 VEO-IBD patients, 44 cases were in the M-IBD group, 35 of whom carried IL-10RA mutations, and the most common mutations were c.301C>T (p.R101W, 30/70) and the c.537G>A (p.T179T, 17/70). The higher the serum TNF-α value was, the greater the risk of diagnosing IBD (OR=1·25, 95%CI: 1·05, 1·50, P=0·013) and the higher serum albumin level meant it was less likely to have IBD (OR= 0·86, 95%CI: 0·74, 1·00, P=0·048). ROC analysis showed that the cut-off values of TNF-α and albumin were 17·40 pg/mL ( sensitivity: 0·78, specificity: 0·88 ) and 36·50 g/L (sensitivity: 0·80, specificity: 0·90), respectively. The increased ferritin level was indicative of a genetic mutation in VEO-IBD patients. Its cut-off value was 28·20 ng/mL (sensitivity: 0·93, specificity: 0·92). Moreover, when IL-10 level was higher than 33·05 pg/ml (sensitivity: 1·00, specificity: 0·84), or the onset age was earlier than 0·21 months (sensitivity: 0·82, specificity: 0·94), it was strongly suggested the presence of disease-causing mutations in IL-10RA in VEO-IBD patients. Interpretation: A high proportion of Mendelian disease was present in VEO-IBD patients, of which IL-10RA was the most common disease-causing gene. Serum TNF-α and albumin level could be used for differentiating VEO-IBD patients from children with allergic proctocolitis, as well as serum ferritin and IL-10 may serve as early screening indicators for monogenic VEO-IBD, thereby shortening the time for disease diagnosis. Funding: This study was funded by Scientific researching fund of Shanghai Municipal Health Commission(No·201640368) and National Natural Science Foundation of China Grant (No·81741103).Declaration of Interests: All authors declare no competing interests.Ethics Approval Statement: This study was approved by the ethics committee of Ruijin Hospital, Shanghai Jiaotong University, School of Medicine. All guardians of the enrolled pediatric patients who experienced the gene test signed an informed consent form.

Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development

Analysis of a child with Very early onset inflammatory bowel disease due to compound heterozygous variants of IL10RA and DUOX2 genes

The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease

Variants in TRIM22 That Affect NOD2 Signaling Are Associated with Very-Early-Onset Inflammatory Bowel Disease.

Defects in NADPH Oxidase Genes NOX1 and DUOX2 in Very Early Onset Inflammatory Bowel Disease

Autosomal Recessive 333 Base Pair Interleukin 10 Receptor Alpha Subunit Deletion in Very Early-Onset Inflammatory Bowel Disease.

IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease

Characterization of Novel and Large Fragment Deletions in Exon 1 of the IL10RA Gene in Chinese Children with Very Early Onset Inflammatory Bowel Diseases

Analysis of Clinical Phenotype and Genotype of 30 Chinese Pediatric Patients Suffering Very Early Onset Inflammatory Bowel Disease

Case Report: A Novel Compound Heterozygous Mutation in IL-10RA in a Chinese Child With Very Early-Onset Inflammatory Bowel Disease

Case Report: A Novel Compound Heterozygous Mutation in <i>IL-10RA</i> in a Chinese Child With Very Early-Onset Inflammatory Bowel Disease

NLRP12 c.1382dup promotes the development of Crohn's disease through the ERK/NLRP3/ IL-1β pathway

ORMDL3 regulates NLRP3 inflammasome activation by maintaining ER-mitochondria contacts in human macrophages and dictates ulcerative colitis patient outcome

Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis

Comprehensive Mutation Screening for 10 Genes in Chinese Patients Suffering Very Early Onset Inflammatory Bowel Disease

A Retrospective Study of 73 Chinese Children with Very Early Onset Inflammatory Bowel Disease (VEO-IBD): Searching for Laboratory Indicators for Early Screening of Patients with Monogenic VEO-IBD

Clinical and Genetic Spectrum of Nine Cases of NLRP3-Associated Autoinflammatory Disease (NLRP3-AID) and Identification of One Novel NLRP3 Mutation by Genetic Variation Analyses

Clinical Phenotypes and Outcomes in Monogenic Versus Non-monogenic Very Early Onset Inflammatory Bowel Disease

NOD2 Polymorphisms May Direct a Crohn Disease Phenotype in Patients With Very Early-Onset Inflammatory Bowel Disease

Deleterious Genetic Variation Across the NOD Signaling Pathway Is Associated With Reduced NFKB Signaling Transcription and Upregulation of Alternative Inflammatory Transcripts in Pediatric Inflammatory Bowel Disease

Identification of a Novel NLRP12 Frameshift Mutation (Val730Glyfs ∗ 41) by Whole-Exome Sequencing in Patients with Crohn’s Disease